Fingerprint
Dive into the research topics of 'Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture
Pan-American Collaborative Retina Study Group (PACORES)
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations